Interpace Diagnostics Selected Fundamentals

    Interpace Diagnostics Group Inc -- Exotistan Stock  

    USD 0.53  0.06  10.17%

    The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

    Beta Analysis

    Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.
    Interpace Diagnostics 

    About Beta

    In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.Compare to competition
    In accordance with recently published financial statements Interpace Diagnostics Group Inc has Beta of -0.05. This is much lower than that of the sector, and significantly lower than that of Beta industry, The Beta for all stocks is over 1000% higher than the company.

    Interpace Diagnostics Fundamental Drivers Relationships

    Interpace Diagnostics Group Inc is considered to be number one stock in shares owned by insiders category among related companies. It is considered to be number one stock in gross profit category among related companies fabricating about  301,660  of Gross Profit per Shares Owned by Insiders.

    Peer Comparison

    Interpace Diagnostics Operating Margin Comparison
      Operating Margin 
          Interpace Diagnostics Comparables 
    Interpace Diagnostics is currently under evaluation in operating margin category among related companies.

    Did you try this?

    Run Crypto Portfolio Optimizer Now

    Crypto Portfolio Optimizer

    Optimize portfolio of digital coins and token across multiple currency and exchanges
    Hide  View All  NextLaunch Crypto Portfolio Optimizer